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https://doi.orExploratory Use of Fluorescent SmartProbes for
the Rapid Detection of Microbial Isolates
Causing Corneal UlcerRAMESHKUMAR GUNASEKARAN, PRAJNA LALITHA, ALICIA MEGIA-FERNANDEZ, MARK BRADLEY,
RACHEL L. WILLIAMS, KEVIN DHALIWAL, N. VENKATESH PRAJNA, AND BETHANY MILLS PURPOSE: To explore the use of optical SmartProbes
for the rapid evaluation of corneal scrapes from patients
with suspected microbial keratitis, as a clinical alternative
to Gram stain.
 DESIGN: Experimental study with evaluation of a diag-
nostic technology.
 METHODS: Corneal scrapes were collected from 267
patients presenting with microbial keratitis at a referral
cornea clinic in South India. Corneal scrapes were flooded
with SmartProbes (BAC One or BAC Two) and evalu-
ated by fluorescence microscopy (without the need for
sample washing or further processing). The
SmartProbe-labeled samples were scored as bacteria/
fungi/none (BAC One) or gram-negative bacteria/none
(BAC Two) and compared to Gram stain results.
 RESULTS: Compared to Gram stain, BAC One demon-
strated sensitivity and specificity of 80.0% and 87.5%,
respectively, positive and negative predictive values
(PPV, NPV) of 93.8% and 65.1%, and an accuracy of
82.2. BAC Two demonstrated sensitivity and specificity
of 93.3% and 84.8%, respectively, an NPV of 99.2%,
and an accuracy of 85.6%. When the corresponding cul-
ture results were compared to the Gram stain result, the
sensitivity and specificity were 73.4% and 70.7%, the
PPV and NPVs were 86.5% and 51.0%, and overall ac-
curacy was 72.6.
 CONCLUSIONS: Fluorescent SmartProbes offer a
comparative method to Gram stain for delineating gram-
positive or gram-negative bacteria or fungi within corneal
scrapes. We demonstrate equivalent or higher sensitivity,
specificity, PPV and NPVs, and accuracy than culture to
Gram stain. Our approach has scope for point-of-care
clinical application to aid in the diagnosis of microbialupplemental Material available at AJO.com.
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M
ICROBIAL KERATITIS (MK) IS AN OCULAR EMER-
gency.1,2 Without microbiological confirmation
of the infecting microbe, appropriate manage-
ment cannot be effectively instigated, particularly so in re-
gions that experience multiple MK etiologies (bacteria,
fungi, or protozoa).3–6 Without rapid and adequate
treatment, corneal infection leads to permanent visual loss
through corneal scarring, corneal perforations, extrusion of
intraocular contents, or intractable secondary glaucoma.7–
11 This diagnostic requirement is particularly pertinent in
high-incidence regions such as South and Southeast Asia
wherew50% of cases are fungal andw50% are bacterial,
and thus require differential antimicrobial treatment.8,12–
15 Current diagnostic methods (direct smear microscopic
examination and/or culture of scraped corneal material)
for MK are somewhat dated, require dedicated
microbiology laboratory infrastructure, and suffer from a
wide variation in their sensitivity and specificity.16
Although culture of microorganisms is considered to be
the gold standard, it may take 2-14 days to yield a diagnosis,
which is positive only 50.5%of the time16,17—valuable time
that cannot be afforded byMK patients. On the other hand,
immediate microscopic evaluation of smears provides infor-
mation on the Gram status of bacteria or the presence of
fungi, but again, staining has been shown to be effective in
MK diagnosis only 27.3%-61.6% of the time.16
An overhaul in the diagnostic approach for MK is
required. The purpose of this exploratory study was to assess
whether fluorescence microscopy and optical molecular
imaging approaches with microbe-specific SmartProbes18–
21 could be an alternative and additive approach to
conventional direct microscopy and/or microbial culture
for cases of suspected MK. Optical molecular imaging of
infection is an emerging field, and here we have
investigated the utility of 2 activatable peptide-based fluo-
rescent imaging probes that have been previously devel-
oped and evaluated for in situ point-of-care pulmonary
applications: BAC One is able to report on the presence
of microbes (bacterial and fungal) through an341LISHED BY ELSEVIER INC.
FIGURE 1. Schematic of BAC One and BAC Two binding to target microbes and activating fluorescence signal. NBD [ fluoro-
phore; PMX [ modified polymyxin B binding domain; UBI [ ubiquicidin29-41 binding domain. Not to scale. Created with
BioRender.com.antimicrobial peptide binding fragment, ubiquicidin
(UBI29-41)
22,23; and BAC Two is able to report on the pres-
ence of gram-negative bacteria; utilizing a derivative of
polymyxin B to bind to lipid A of the gram-negative cell
wall.24 In both cases, the fluorophore incorporated into
the compound is 7-nitrobenz-2-oxa-1,3-diazole (NBD),
an environmentally sensitive dye that self-quenches in
aqueous environments but fluoresces strongly in hydropho-
bic environments,25 such as the microbial membrane, thus
enabling wash-free detection of positive samples, providing
ease of sample preparation and a high signal-to-noise ratio
(Figure 1).
We assessed BAC One and BAC Two on 267 clinical
corneal scrapes and evaluated their accuracy to detect
gram-positive, gram-negative, or fungal isolates compared
to clinical gold standards at a tertiary referral eye care cen-
ter in South India.METHODS
 STUDY DESIGN: The primary objective of this study was
to determine the efficacy of the SmartProbes, BAC One
and BAC Two, toward the identification of bacteria or
fungi within clinical corneal scraping samples by fluores-
cence microscopy. These SmartProbes are not available
commercially. A prospective experimental laboratory study
was conducted on 267 patients clinically diagnosed with
corneal ulcer during the study period from March 2018 to
July 2018. Approval was obtained from the Institutional
Review Board of Aravind Eye Hospital, Madurai, India,
for this study, and the research adhered to the tenets of342 AMERICAN JOURNAL OFthe Declaration of Helsinki. After informed consent was
obtained from all patients, the corneal material was
collected from the infected eye by standard clinical proced-
ure under topical anesthesia (0.5% proparacaine). Speci-
mens included 3 scrapings for smear examination (1 each
for Gram stain, 10% KOH wet mount, and labeling with
BAC probes [BAC One or BAC Two]). A final scrape
was collected for culture on blood agar and potato dextrose
agar. Gram stain, KOH staining, and culture were
performed as per standard clinical practice. Identification
of the bacteria or fungi was based on the colony
morphology and standard biochemical procedures. Infor-
mation regarding demographic details, predisposing fac-
tors, clinical course, treatment, and visual outcome was
also collected during the study period. The results obtained
by fluorescence microscopy with the SmartProbes did not
inform any clinical decisions or patient management.
 IN VITRO VALIDATION OF BAC ONE AND BAC TWO
WITH OCULAR PATHOGENS: BAC One and BAC Two
have previously been evaluated against a panel of lung
pathogens.23,24 Here they were evaluated against clinically
isolated ocular pathogens; bacterial isolates Staphylococcus
epidermidis (gram-positive) and Pseudomonas aeruginosa
(gram-negative); and fungal isolates Aspergillus flavus and
Fusarium spp. Colonies were sampled from solid media
with a toothpick and smeared onto a glass slide within
20 mL saline. The slides were allowed to dry and underwent
staining with BAC One or BAC Two, either immediately
or after 5 hours storage on the bench (to mimic clinical sce-
narios). A total of 20 mL of each SmartProbe (5 mM in sa-
line) was added directly to the slide, as appropriate, and the
sample was mounted with a coverslip and sealed with nailNOVEMBER 2020OPHTHALMOLOGY
polish. The samples were immediately interrogated by fluo-
rescence microscopy (Zeiss Axio Scope A1 (Carl Zeiss Mi-
croscopy GmbH, Jena, Germany), FITC filters, 1 s
integration time).
 PREPARATION OF BAC ONE AND BAC TWO CLINICAL
SPECIMENS: Corneal scrapes were collected under standard
clinical conditions. A total of 20mL of 5mMBACOne (for
patient samples collected between March 9, 2018, and
April 20, 2018) or BAC Two (for patient samples collected
between April 23, 2018, and July 31, 2018) was added
directly to the specimen on the same day following collec-
tion. A coverslip was added directly to the sample and
sealed with nail polish. Clinical-grade BAC One and
BAC Two were synthesized and characterized in-house at
the University of Edinburgh as previously described.23,24
ASSESSMENT OF BAC ONE AND BAC
TWO: TRAINING SET
THE MICROBIOLOGIST SCORING THE LABELED CLINICAL
samples trained by examining 50 samples with prior knowl-
edge of the Gram stain result. Slides were examined with a
Nikon Eclipse 50i fluorescence microscope, with Nikon
Mercury lamp and FITC filters (Nikon, Tokyo, Japan).
Visualization of the sample was performed using a 403
objective.
ASSESSMENT OF BAC ONE AND BAC
TWO: CLINICAL SAMPLES
THE EXAMINING MICROBIOLOGIST WAS THEN MASKED TO
the Gram stain and culture result when scoring the BAC
One (n ¼ 107) and BAC Two (n ¼ 160) samples by fluo-
rescence microscopy as outlined above. Representative im-
ages, for display purposes, were captured using a smartphone
(Huawei P-smart, model FIG-LX1 (Huawei Technologies
Co., Ltd, Shenzhen, China)) held over the eye-piece. Image
capture was performed with fixed manual settings
(including ISO, shutter, and exposure valuation) to enable
comparison between samples, followed by brightness and
contrast enhancement with Fiji_ImageJ for presentation.
Following BACOne or BACTwo bacterial/fungal/negative
scoring, the sample was compared to both Gram stain result
and microbiological culture result, which had been
captured according to the standard clinical procedure.
 STATISTICALANALYSIS: Sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV),
and accuracy scores, including 95% confidence intervals
were calculated using Prism 8.4 (GraphPad Software, San
Diego, CA, USA). The same software was used for plotting
the graphical representations of the data.VOL. 219 OPTICAL SMARTPROBES TO IDENTIFYRESULTS
 CLINICAL DIAGNOSIS OF CORNEAL SAMPLES: Following
informed consent, corneal scrapes were collected from 267
patients presenting with suspected MK within the corneal
clinic at Aravind Eye Hospital, Madurai, South India be-
tween the months of March-April 2018 (Cohort 1, BAC
One) and April-July 2018 (Cohort 2, BAC Two). Scrapes
were collected for standard clinical diagnosis by direct mi-
croscopy (Gram stain) and culture. Although direct obser-
vation of stained corneal smears provides a rapid
preliminary indication of causative microbial etiology, cul-
ture remains the clinical gold standard. A summary of
Gram stain results compared to the clinical gold standard
attained within this study is shown in Table 1.
Of the 267 corneal samples collected, following microbi-
al culture, 112 (41.9%) had fungal growth alone and 47
(17.6%) had bacterial growth alone. One eye (0.4%) had
Acanthamoeba only and the remaining 104 (39%) had no
growth. Three corneal samples cultured 2 organisms; all 3
grew gram-negative bacteria plus fungi (in 2 cases) and
Acanthamoeba (in 1 case).
Supplemental Table 1 (Supplemental Material at AJO.
com) presents the spectrum of microbial isolates isolated
from the 163 corneal samples with culture-confirmed
MK. A total of 166 microbial isolates were isolated, of
which 30% were bacterial and 69% were fungal. The
most common bacterial isolate was Pseudomonas aeruginosa
(25, 15.1%), followed by Streptococcus pneumoniae (8,
4.8%). Fusarium species (39, 23.5%) and Aspergillus flavus
(22, 13.3%) were the most commonly isolated fungal
pathogens.
When the same 267 clinically retrieved corneal samples
were examined by direct observation (Gram stain and mi-
croscopy), 200 (75%) were positive for microbial patho-
gens, compared to 61% that were culture positive. A
total of 146 (54.7%) were positive for fungi, 49 (18.3%)
were positive for bacteria, and 4 (1.5%) smears had mixed
organisms. One sample (0.4%) was positive for Acantha-
moeba and the remaining 67 (25.1%) had no discernable
microbe identified.
 IN VITRO VALIDATION OF BAC ONE AND BAC TWO ON
MICROBIAL KERATITIS PATHOGENS: We have previously
demonstrated that BAC One is able to fluorescently label
gram-positive and gram-negative bacteria, and Aspergillus
fumigatus23 in vitro, without the requirement of removal
of unbound, excess probe prior to visualization by confocal
fluorescence microscopy. Similarly, BAC Two was shown
to be selective to gram-negative bacteria in our previous
work.24 Here we validated the selectivity of both BAC
One and BAC Two on clinically isolated ocular pathogens
from patients with microbial keratitis, which were smeared
directly onto slides (mimic of clinical specimens) to opti-
mize our labeling procedure, determining that a concentra-
tion of 5 mM was optimal for specific microbe labeling and343MICROBES IN CORNEAL ULCER
TABLE 1. Correlation Between Direct Microscopy (Gram Stain)–Based and Microbial Culture–Based Diagnosis of Microbial Keratitis
Direct Microscopy
TotalGram-positive Bacteria Gram-negative Bacteria Fungi Amoeba Mixed species Negative
Culture
Gram-positive bacteria 13 (72.2%)* 0 1 (5.6%) 0 1 (5.6%) 3 (16.7%) 18 (6.7%)
Gram-negative bacteria 1 (3.4%) 23 (79.3%)* 0 0 0 5 (17.2%) 29 (10.9%)
Fungi 1 (0.9%) 1 (0.9%) 103 (92%)* 0 1 (0.9%) 6 (5.4%) 112 (41.9%)
Amoeba 0 0 0 1 (100%)* 0 0 1 (0.4%)
Mixed species 0 0 2 (66.7%) 0 1 (33.3%)* 0 3 (1.1%)
Negative 3 (2.9%) 7 (6.7%) 40 (38.5%) 0 1 (1%) 53 (51%)* 104 (39.0%)
Total 18 (6.7%) 31 (11.6%) 146 (54.7%) 1 (0.4%) 4 (1.5%) 67 (25.1%) 267
Asterisk indicates corroborating results between the 2 compared methodologies.imaging using a wide-field fluorescent microscope. BAC
One was able to label all bacterial and fungal strains
(Figure 2A), while BAC Two enabled specific labeling of
the gram-negative bacterium P. aeruginosa ocular isolate,
and did not demonstrate any off-target labelling of gram-
positive S. epidermidis or Fusarium (Figure 2B). One small
A. flavus filament did appear to produce a positive BAC
Two signal (Figure 2B, white arrow); however, the
morphology was clearly distinct from that of bacteria.
 BACONEANDBACTWOOFFEREQUIVALENTORBETTER
SENSITIVITY AND SPECIFICITY COMPARED TO GOLD-
STANDARD ASSESSMENTS: Each patient specimen (n ¼
267) underwent direct microscopy (Gram stain) and mi-
crobial culture as part of standard clinical practice, the re-
sults of which are outlined above (Table 1 and
Supplemental Table 1). BAC One (n ¼ 107) or BAC
Two (n ¼ 160) was added to 1 additional clinical smear
as appropriate, and the scoring microbiologist was masked
to the clinical diagnosis while assessing the BAC One/
BAC Two–labeled slide by fluorescence microscopy.
Table 2 and Supplemental Figure 1 (Supplemental Ma-
terial at AJO.com) present the summary comparison of
sensitivity, specificity, PPV and NPV, and the overall accu-
racy of BAC One, BAC Two, and culture compared to
direct microscopy following Gram stain. Comparisons to
the microbial culture are reported in Supplemental
Table 2 and Supplemental Figure 2 (Supplemental Mate-
rial at AJO.com). Both BAC One and BAC Two demon-
strated equivalent or increased sensitivity, specificity, and
accuracy toward the Gram stain result compared to micro-
bial culture, as determined by overlapping (equivalent) or
nonoverlapping (improved or reduced performance) 95%
confidence intervals. The low PPV for BAC Two (second
row of Table 2; based on fluorescence only) toward identi-
fying gram-negative bacteria was attributed to the small
proportion (19.5%) of fungal isolates that were recorded
as fluorescent. The morphology of the BAC Two–labeled344 AMERICAN JOURNAL OFfungi did enable a classification that was distinct from bac-
teria, and when morphology was considered (third row of
Table 2) the PPV increased from 38.9% to 88.9%.
Although BAC Two labeling of fungal isolates was not
anticipated, we were able to demonstrate that smeared
fungal isolates left on the bench for 4-5 hours prior to addi-
tion of BAC Two did exhibit some fluorescence
(Supplemental Figure 3, Supplemental Material at AJO.
com) that was not observed when BAC Two was added
within an hour of culture smear (Figure 2). Moreover, it
is widely reported that fungi exhibit some autofluorescence
at this wavelength, and that may be a contributing factor.
 COHORT 1: BAC ONE: BAC One fluorescence is an indi-
cator of microbial presence. With the addition of morpho-
logic validation (ie, size and shape), it was possible for the
operator to score the slide as ‘‘Bacteria,’’ ‘‘Fungi,’’ or ‘‘Nega-
tive,’’ but it was not possible to delineate the Gram status.
The results were compared to the immediate Gram stain
result and the microbial culture result (Table 3). In sum-
mary, 87 (81.3%) of BAC One scored samples matched
the smear microscopy (Gram stain) result, and 81
(75.7%) matched the microbial culture result. By compar-
ison, 72 (67.3%) of smear microscopy samples matched the
microbial culture results (Supplemental Table 3, Supple-
mental Material at AJO.com). Representative images
from both the Gram stain (obtained with a 1003 objective
under oil immersion) and fluorescence imaging (obtained
with a 403 objective) are shown in Figure 3. In all in-
stances, the images were captured via a smartphone camera
down the eye-piece and therefore the size of the field-of-
view (FOV) within the image cannot be deduced and
varies between images.
BAC One vs Direct Microscopy. A total of 45 of 54
(83.3%) of the clinical samples were positive for fungi based
on both direct microscopy (Gram stain) and fluorescence
microscopy (BAC One). The remaining 9, which wereNOVEMBER 2020OPHTHALMOLOGY
FIGURE2. BACOne labels all microbes, and BACTwo is selective for gram-negative bacteria. BACOne (A) (5mM) andBACTwo
(B) (5 mM) were added to smears of ocular clinical isolates (Pseudomonas aeruginosa, Staphylococcus epidermidis, Fusarium, and
Aspergillus flavus) and imaged by wide-fluorescence microscopy using 488 nm excitation and FITC filters. White arrow shows fluo-
rescent fungal filament. Scale bar[ 50 mM.fungal positive by direct microscopy, were BAC One nega-
tive. There was also excellent similarity in results for
microbe-negative samples between the 2 modalities, with
28 of 32 (87.5%) of negative direct microscopy samples
also being scored as fluorescence negative. The largest
discrepancy lay in the reporting of bacterial samples. Only
14 of the 21 (66.7%) bacterial specimens identified by
direct microscopy were recorded as positive by
fluorescence microscopy, 6 (28.6%) were recorded as
negative (5 of 6 were culture negative), and 1 was
positive for fungus (and culture positive for fungus). This
could be attributed to scarcity of bacteria within the
sample or be due to the comparatively smaller size of
bacterial cells compared to fungi, which may be difficult
to visualize at 403 magnification, particularly if the
sample had a large amount of autofluorescent tissue present.
BAC One vs Culture. A total of 14 of 17 (82.4%) bacte-
rial and 32 of 37 (86.5%) fungal specimens determined by
culture were also BAC One positive. The remaining
culture-positive samples were recorded as BAC One
negative. The major discrepancy between the microbial
culture and BAC One scoring was for culture-negative
samples. Although they matched in two-thirds of cases
(35/53), 16 samples (30.2%) that were culture negative
were fungal positive by fluorescence imaging (and also
Gram stain), with the remaining 2 positive for bacteria
(by fluorescence imaging and Gram stain).VOL. 219 OPTICAL SMARTPROBES TO IDENTIFY COHORT TWO: BAC TWO: BAC Two should enable the
selective identification of gram-negative bacteria based on
fluorescence (ie, without requiring morphologic data to be
observed). BACTwo was validated against 160 patient sam-
ples. While BAC Two offered >_90% identification of gram-
negative specimenswithin this studywhencompared to both
the Gram stain result and the microbiological culture result
(Table 4), there was fluorescent signal recorded forw20% of
the fungal samples, thus accounting for the relatively low
PPV reported in Table 2 (second row). Despite this, sensi-
tivity and specificity values of 90% and 87.1%, respectively,
were achieved by using BAC Two as a diagnostic tool for
gram-negative bacteria, based on fluorescence only. When
themorphology informationwas added alongside the fluores-
cence information the PPV was increased to 97.2% (vs
50.0% without morphology data) (Table 2, third row).
The addition of morphologic information further increased
the sensitivity and specificity compared to the Gram stain
with respect to the microbial culture results.
In summary, 137 (85.6%) of BAC Two scored samples
matched the smear microscopy (Gram stain) result, (96.9%
when fungal-positive isolates were included), and 141
(88.1%) matched the microbial culture result (98.8% when
fungal-positive isolates were included). By comparison, 121
(75.6%) of smear microscopy samples matched the microbial
culture results for these patients (Supplemental Table 4, Sup-
plemental Material at AJO.com). Representative images
from both the Gram stain (obtained under oil immersion345MICROBES IN CORNEAL ULCER
TABLE 3. Correlation Between Direct Microscopy (Gram Stain)–, Culture–, and Optical Image Probe Assay (BAC One)–Based
Diagnosis of Microbial Keratitis
BAC One
TotalBacteria Fungi Negative
Direct microscopy
Bacteria 14 (66.7%)* 1 (4.7%) 6 (28.6%) 21 (19.6%)
Fungi 0 45 (83.3%)* 9 (16.7%) 54 (50.5%)
Negative 2 (6.25%) 2 (6.25%) 28 (87.5%)* 32 (29.9%)
Total 16 (15%) 48 (44.8%) 43 (40.2%) 107
Culture
Bacteria 14 (82.4%)* 0 3 (17.6%) 17 (15.9%)
Fungi 0 32 (86.5%)* 5 (13.5%) 37 (34.6%)
Negative 2 (3.8%) 16 (30.2%) 35 (66%)* 53 (49.5%)
Total 16 (15%) 48 (44.8%) 43 (40.2%) 107
Asterisk indicates corroborating results between the 2 compared methodologies.
TABLE 2. Comparison of BAC One, BAC Two, and Microbial Culture to Gram Stain Scoring
Vs Direct Microscopy
Sensitivity (95 % CI) Specificity (95 % CI) PPV (95 % CI) NPV (95 % CI) Accuracy (95 % CI)
BAC One 80.0 (69.6-87.5) 87.5 (71.9-95.0) 93.8 (85.0-97.5) 65.1 (50.2-77.6) 82.2 (73.7-89.0) n ¼ 107
BAC Twoa 93.3 (70.2-99.7) 84.8 (78.1-89.8) 38.9** (24.8-55.1) 99.2* (95.6-100) 85.6* (79.2-90.7) n ¼ 160
BAC Twob 97.0* (84.7-99.8) 96.9* (92.2-98.8) 88.9 (74.7-95.6) 99.2* (95.6-100) 96.9* (92.9-99.0) n ¼ 160
Culture 73.4 (66.8-79.2) 70.7 (59.6-79.8) 86.5 (80.4-90.9) 51.0 (44.5-60.4) 72.6 (66.9-77.9) n ¼ 267
CI ¼ confidence interval; NPV ¼ negative predictive value; PPV ¼ positive predictive value.
All values presented as%. Value with no asterisk indicates ‘‘equivalence,’’ single asterisk indicates ‘‘superior,’’ and double asterisk indicates
‘‘inferior,’’ determined by overlapping/separated CIs with Culture.
aBAC Two–labeled fungi samples classified as false-positive (no morphology consideration).
bFungi-positive samples classified as true-positives based on fluorescence plus morphology.with a 1003 objective) and fluorescence imaging (obtained
with a 403 objective) are shown in Figure 4. In all instances,
the images were captured via the smartphone camera down
the eye-piece, and therefore the size of FOVwithin the image
cannot be deduced and varies between images.
BAC Two vs Smear Microscopy. Fourteen of the 160 pa-
tient samples were recorded as gram-negative based on
direct smear microscopy. Thirteen of these 14 (92.9%)
were also identified as gram-negative bacteria based on
BAC Two fluorescence imaging and morphology.
Eighteen of 92 (19.6%) fungal specimens identified by
direct microscopy were also positive for fluorescence.
These could readily be distinguished from bacterial
samples based on the size and morphology of the
organism. As expected, it is noteworthy that BAC Two
did not identify any gram-positive bacteria, as determined
by Gram stain.346 AMERICAN JOURNAL OFBAC Two vs Culture. Twenty of 160 specimens were
recorded as gram-negative following microbial culture; 18
of these (90%) were also BAC Two positive. In concor-
dance with the direct microscopy results, 17 of the 18
fungal-positive fluorescent samples were also cultured as
fungal positive, and BAC Two did not enable any
identification of gram-positive bacteria, as determined by
microbial culture. Of the fungal isolates that were
fluorescent, 9 were A. flavus, 4 were Fusarium spp., 1 was
Pythium insidiosum, 2 were unidentified hyaline fungi, and
1 was unidentified dematiaceous fungi.DISCUSSION
THE IDEAL TREATMENT FOR A CORNEAL ULCER SHOULD BE
tailored based on microbiological guidance rather thanNOVEMBER 2020OPHTHALMOLOGY
FIGURE 3. BAC One allows identification of all microbes. Representative bright-field and fluorescent images of corneal scrapes
following Gram stain and BAC One treatment. Bright-field images were viewed with 1003 objective under oil immersion; fluores-
cence images were viewed with 403 objective using 488 nm excitation and FITC filters. A smartphone camera with fixed settings was
used to capture images via the microscope eye-pieces.clinical presentation, where visual delineation between
bacteria and fungi is known to be challenging.5,6 However,
except for tertiary care facilities with dedicated microbio-
logical setup, anecdotal experiences suggest that empirical
treatment is being initiated based on clinical appearance of
MK. The reasons for this may be nonavailability of trained
microbiologists and less-than-optimum results obtained by
current smear and culture,3,4,16 the reasons for which can
include prior antimicrobial use, low microbe numbers
within the smear, and inexperienced microbiologists. It is
evident that alternative, cost-effective approaches to MK
diagnosis are required.
Indeed, many of the drawbacks of direct smear micro-
scopy from MK patient smears are similar to those encoun-
tered by operators examining sputum smear samples from
suspected tuberculosis patients that have been stained
with colored dyes.26 Vast improvements have been
achieved in the field of tuberculosis sputum smear micro-
scopy through the incorporation of fluorescence micro-
scopy and Mycobacteria-specific fluorescent stains (such as
auramine and rhodamine), leading to increased sensitivity,
particularly with low-grade positives, while retaining spec-
ificity. Fluorescence dyes also enable slides to be examined
at a lower magnification compared to nonfluorescent
colored dyes, increasing the FOV, thus reducing both oper-
ator time and fatigue.
Our ambition was to evaluate the potential of using fluo-
rescent SmartProbes to label ocular pathogens within
corneal scrapes, and to compare the sensitivity and speci-VOL. 219 OPTICAL SMARTPROBES TO IDENTIFYficity of our technique to direct microscopy and culture.
To this end, we selected 2 optical SmartProbes (BAC
One and BAC Two) for incorporation into this study,
which we have previously evaluated clinically for in situ,
point-of-care pulmonology applications.23,24 However,
their efficacy toward MK pathogens, the sample type (hu-
man corneal scrape, which will likely include tissue debris
and dead microbes), and the sample handling chain were
unknown at the outset of this study. We were able to
demonstrate wash-free labeling of bacteria and fungi by
BAC One (using a combination of fluorescence and
morphology to delineate between the two) with an accu-
racy of 82.2% compared to direct microscopy (Gram stain)
and 75.2% compared to culture (there was a 72.6% accu-
racy between direct microscopy and culture).
BAC Two was only anticipated to identify gram-
negative bacteria; however,w20 percent of fungal samples
were also recorded as fluorescent within the BAC Two
cohort. While this could be a demonstration of off-target
labeling of samples that had been left on the bench
throughout the work day (as we were able to show in
Supplemental Figure 3), it may also be a product of fungal
autofluorescence, which has been reported within the liter-
ature for UV and blue-light excitation, as used within this
study.27 Further work using fluorescence intensity thresh-
olding is warranted to fully characterize the underlying
contribution of off-target labeling with these fungal sam-
ples. Importantly, those BAC Two–positive fungal speci-
mens were all characterized as fungi based on the347MICROBES IN CORNEAL ULCER
TABLE 4. Correlation Between Direct Microscopy (Gram Stain)–, Culture–, and Optical Image Probe Assay (BAC Two)–Based
Diagnosis of Microbial Keratitis
BAC Two
TotalGram-positive Bacteria Gram-negative Bacteria Fungi Amoeba Negative
Direct microscopy
Gram-positive bacteria 0 0 0 0 15 (100%) 15 (9.4%)
Gram-negative bacteria 0 13 (92.9%)* 0 0 1 (7.1%)
Fungi 0 1 (1.1%) 18 (19.6%)** 0 73 (79.3%) 92 (57.5%)
Amoeba 0 0 0 0* 1 (100%) 1 (0.6%)
Mixed organisms 0 1a (33.3%)* 0 0 2 (66.7%) 3 (1.9%)
Negative 0 3 (8.6%) 0 0 32 (91.4%)* 35 (21.9%)
Total 0 18 (11.25%) 18 (11.25%) 0 124 (77.5%) 160
Culture
Gram-positive bacteria 0 0 0 0 13 (100%) 13 (8.1%)
Gram-negative bacteria 0 16 (94.1%)* 0 0 1 (5.9%) 17 (10.6%)
Fungi 0 0 17 (22.7%)** 0 58 (77.3%) 75 (46.9%)
Amoeba 0 0 0 0* 1 (100%) 1 (0.6%)
Mixed organisms 0 2a (66.7%)* 0 0 1 (33.3%) 3 (1.9%)
Negative 0 0 1 (2%) 0 50 (98%)* 51 (31.2%)
Total 0 18 (11.25%) 18 (11.25%) 0 124 (77.5%) 160
Single asterisk indicates corroborating results between the 2 compared methodologies. Double asterisk indicates corroborating results, but
unexpected for BAC Two.
aPositive for gram-negative bacteria by direct microscopy and/or culture.
FIGURE 4. BAC Two selectively labels gram-negative bacteria over gram-positive. Representative bright-field and fluorescent im-
ages of corneal scrapes following Gram stain and BAC Two incubation. Bright-field images were viewed with 1003 objective under
oil immersion; fluorescence images were viewed with 403 objective using 488 nm excitation and FITC filters. A smartphone camera
with fixed settings was used to capture images via the microscope eye-pieces.White arrow shows fluorescently labeled microorganism.morphology of the cell. Vitally, no off-target labeling of
gram-positive bacteria was observed, which is the key moti-
vation for using BAC Two, as BACOne is unable to differ-348 AMERICAN JOURNAL OFentiate bacteria based on Gram status. Thus when signal
and morphology were taken into consideration, an accu-
racy score of 96.9% was reached, with sensitivity,NOVEMBER 2020OPHTHALMOLOGY
specificity, and NPV all above 95% compared to direct
smear microscopy and microbial culture.
In all cases, we found that BAC One and BAC Two ex-
amination provided equivalent, if not better, corroboration
to the direct microscopy (Gram stain) and culture results
than direct microscopy did to culture (as demonstrated by
overlapping [for equivalence] or nonoverlapping [for
improved] 95% confidence intervals). Additionally, our
approach enabled simple sample processing, with the
SmartProbe added directly to the slide and coverslip added
without any fixation or wash procedure, and the fluores-
cence microscopy technique was readily learned by the
microbiologist. We were also able to demonstrate that a
403 microscope objective was sufficient for screening the
SmartProbe-labeled slides, compared to the use of a 1003
objective for direct microscopy, thus enabling a larger
FOV to be examined, making slides quicker and easier to
examine. It should also be noted that 75% of the patients
within our study were microbe positive based on Gram
stain. This is in contrast to 27.3%-61.6% reported within
the literature.16 Microbial culturing was only slightly better
than reported within the literature, thus suggesting that the
microscopist conducting the Gram stain procedure and im-
aging within this study was highly skilled; and thus the
value of our proposed BAC One and BAC Two approach,
with its simplified processing steps and ease of imaging,
may indeed be increased in other laboratory scenarios,
although this warrants further investigation.
Although in the past, fluorescent microscopes have been
prohibitively expensive and considered specialist equip-
ment, there has been a recent concerted effort to innovate
low-cost optical systems that can be brought to the point-
of-care, rather than located within centralized core labora-VOL. 219 OPTICAL SMARTPROBES TO IDENTIFYtories.28–31 We believe that such systems could be used for
our optical molecular imaging approach, and may be
particularly useful for centers that do not have in-house
microbiology laboratories or facilities for preparing samples
for Gram stain or growing culture.32 We anticipate that
such devices could eventually enable automation of fluores-
cence and morphology detection, negating the need for
highly skilled on-site microbiologists to examine each
sample.
Here we have taken the first step in demonstrating effi-
cacy of 2 well-characterized ‘‘lung’’ SmartProbes on a large
(n ¼ 267) ophthalmic clinical sample set and determined
that performance is at least equivalent to clinical direct mi-
croscopy (Gram stain) when compared to culture (the clin-
ical gold standard). Preparation and examination of the
samples fit well within usual laboratory procedure. Addi-
tionally, performance may be further enhanced with the
development and incorporation of specific fungal SmartP-
robes,33 particularly if developed in a shifted spectral win-
dow to BAC One or Two, which will enable wash-free
multiplexing.
In conclusion, we have shown that fluorescent SmartP-
robes offer a comparative method to direct microscopy
(Gram stain) for delineating gram-positive or gram-
negative bacteria or fungi within corneal scrapes, demon-
strating equivalent or higher levels of sensitivity, speci-
ficity, PPV and NPV, and accuracy than culture to Gram
stain, without the need for sample fixation or washing.
We believe that this work opens an exciting avenue for
modernizing the diagnosis of microbial keratitis and has
true clinical tractability, with the potential to bring user-
friendly, cost-effective microbial keratitis diagnosis to the
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